iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE:LSE) Annual Income Statement ()
BTEE:LSE Quarterly Financials ()
Frequently Asked Questions About iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE:LSE) Stock
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s (BTEE:LSE) last reported annual revenue was N/A.
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s (BTEE:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) is not profitable as of its last reported annual financials.
The net profit margin for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its laster reported year is N/A
The return on equity (ROE) for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its last reported annual financials is : N/A
The return on assets (ROA) for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its last reported annual financials is : N/A
The Debt to Equity ratio for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its last reported annual financials is : N/A
The dividend yield for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) from its laster reported year is 0.39%
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)'s(BTEE:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BTEE:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
